Migraine Trust

June 7, 2012 | By More

logo migraine trust 150x150 Migraine TrustThe Migraine Trust is a health and medical research charity for people living with migraine in the UK. It was founded in 1965 and since then has invested over £3 million in 130 research projects.

Migraine is a condition of recurring headaches, which may be linked with other symptoms such as sensitivity to light and noise, feeling sick and dizziness. Migraine affects 8 million people in the UK, and the charity is working towards raising awareness of it as a serious public health issue.

The Migraine Trust funds research projects that examine the biology of the condition, its causes and how its management and treatment may be improved for sufferers. They also provide services such as:

  • Factsheets and information, with advice on diagnosis, triggers and treatments
  • Specialised information packs for migraine in young sufferers, and how to manage it in the workplace
  • An information and enquiry service
  • An advocacy service, to enable sufferers to claim entitlements, avoid discrimination and assert their rights
  • An online migraine diary, where people can keep a record of triggers, medication and level of pain. This helps with managing migraine and can be used by doctors to help with diagnosis.

Objectives

The Migraine Trust’s mission is to “fund and promote research towards a greater understanding of migraine and its underlying mechanisms. The goals of research include improved management and treatment, but the ultimate aim is for a cure”.

Contact details

By post

The Migraine Trust
52-53 Russell Square
London
WC1B 4HP

By phone:
020 7631 6970 (general), 020 7631 6975 (information and enquiry service)

By email:
info@migrainetrust.org or via online enquiry form at http://www.migrainetrust.org/contact

Web:
www.migrainetrust.org

FBlogo Migraine Trust Follow the Migraine Trust on Facebook >
Twitter1 Migraine Trust Follow the Migraine Trust on Twitter >
share save 171 16 Migraine Trust

Category: Founder member, Head, Member

Comments are closed.